HCA Healthcare beats estimates with $20.23B in quarterly revenue
What's the deal? HCA HealthcareDealroom has a profile for this one. Try Dealroom → reported $20.23 billion in revenue for the quarter ended July 24, 2026, beating the consensus estimate of $19.76 billion. Earnings came in at $7.59 per share, ahead of the $7.56 analysts expected.
Why it matters. Revenue rose 8.7% from the same quarter in 2025, when the company earned $6.84 per share. The results topped forecasts on both the top and bottom lines.
The money moves. Westpac Banking CorpDealroom has a profile for this one. Try Dealroom → acquired a new stake of 11,922 shares worth roughly $4.648 million in Q2 2026, according to its latest filing. Institutional investors now hold 62.73% of the stock.
The dividend. HCA declared a quarterly dividend of $0.78 per share, payable on September 30, 2026, to holders of record on September 16. That works out to $3.12 annualised and a yield of 0.7%, with a payout ratio of 10.45%.
Analyst view. UBSDealroom has a profile for this one. Try Dealroom → cut its price target to $579 from $635, while MizuhoDealroom has a profile for this one. Try Dealroom → lowered its objective to $475 from $525. Fourteen analysts have issued Buy ratings, eight have given a Hold rating and one has assigned a Sell rating. The consensus is Moderate Buy, with an average price target of $462.64.
Read more: Ticker Report
Image credit: Medill DC
